Transgenerational Effects and Heritability of Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorder.

This study looked at special antibodies (FRAAs) in families affected by autism. Researchers found these antibodies are passed down from parents to children and tend to increase across generations, especially in families with multiple autistic children. Children with autism had higher levels than their siblings without autism. The study suggests these antibodies might contribute to autism development through effects on the immune system and brain development.

This study examined Folate Receptor Alpha Autoantibodies (FRAAs) in 82 children with ASD, their family members, and controls to investigate transgenerational transmission patterns. Researchers found that known ASD risk factors (multiplex families, multiple births, advanced parental age) were associated with higher offspring FRAA levels. Maternal and offspring FRAA levels showed significant correlation, with levels increasing across generations, particularly in multiplex families. Children with ASD had higher blocking FRAA levels than unaffected siblings.

Paternal FRAA levels correlated with offspring behavioral and cognitive measures. The findings suggest FRAAs may represent heritable non-genetic factors contributing to ASD etiology through autoimmune mechanisms affecting brain development.

Findings suggest FRAAs may serve as potential biomarkers for ASD risk assessment and could inform family counseling. The transgenerational transmission pattern may help identify at-risk families. However, clinical applications require validation through larger prospective studies before implementation in practice.

Study design not specified in abstract. Reanalysis of previous data may limit interpretation. Causal relationships between FRAAs and ASD cannot be established. Sample sizes for subgroups not provided. Mechanism linking FRAAs to ASD development remains unclear.

Autism Spectrum Disorder (ASD) affects an estimated prevalence of 1 in 31 children but the cause in most cases is unknown. Human and animal studies have linked ASD to Folate Receptor Alpha Autoantibodies (FRAAs). Our previous studies demonstrated that FRAAs are more common, on average, in families with children with ASD. This study reanalyzed data from a previous study which included 82 children diagnosed with ASD, 53 unaffected siblings, 70 mothers, 65 fathers, and 52 typically developing controls who did not have a history of ASD in their family.

This study investigates the association of FRAA titers with ASD risk factors and explores the relationship of FRAA titers across generations. Several known risk factors for ASD, including multiplex ASD families, multiple birth pregnancies, and increased maternal and paternal ages at birth, were related to offspring FRAA titers. Multiplex ASD families demonstrated higher FRAA titers. Significant correlation were found between maternal and offspring blocking FRAA titers.

FRAA titers increased across generations, although the increase in blocking FRAA titers was only seen in multiplex families. The proband with ASD showed higher blocking but not higher binding, FRAA titers compared to their non-affected siblings. Paternal FRAA titers are associated with several measures of offspring behavior and cognitive development. This research highlights the potential transgenerational transmission of FRAAs and their role in ASD.

This supports the notion that heritable non-genetic factors may be important in the etiology of ASD and that FRAAs may demonstrate anticipation (worsening across generations), especially in multiplex families. FRAAs may provide one example of the possibility that susceptibility to autoimmune processes may contribute to disrupted brain development and function in ASD.